Low M - Search Results

1

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia.

Ling VY, Lee D, Mcquilten Z, Avery S, Low M, Cody SH, Nguyen T, Mclean C, Gorniak M, Wei A, Ting SB. Ling VY, et al. Among authors: low m. Am J Hematol. 2015 Dec;90(12):E219-20. doi: 10.1002/ajh.24179. Epub 2015 Oct 8. Am J Hematol. 2015. PMID: 26317398 Free article. No abstract available.

2

High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.

Low M, Lee D, Coutsouvelis J, Patil S, Opat S, Walker P, Schwarer A, Salem H, Avery S, Spencer A, Wei A. Low M, et al. Intern Med J. 2013 Mar;43(3):294-7. doi: 10.1111/j.1445-5994.2012.02868.x. Intern Med J. 2013. PMID: 22757980 Review.

3

Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains.

Lee D, Kalff A, Low M, Gangatharan S, Ho P, Bajel A, Ritchie D, Grigg A, Spencer A. Lee D, et al. Among authors: low m. Br J Haematol. 2013 Aug;162(3):371-5. doi: 10.1111/bjh.12404. Epub 2013 May 29. Br J Haematol. 2013. PMID: 23718539 Free article.

4

Detectable CD8 cells correlate with improved overall survival in adult B lymphoblastic leukaemia patients.

Low M, Lee D, McLean C, Nguyen T, Morgan S, Grigoriadis G. Low M, et al. Br J Haematol. 2014 Jun;165(6):883-5. doi: 10.1111/bjh.12794. Epub 2014 Mar 3. Br J Haematol. 2014. PMID: 24588383 Free article. No abstract available.

5

Two cases of refractory IgG4-related disease successfully treated with tocilizumab.

Ong J, Brown S, Gilbertson M, Grigoriadis G, Simpson I, Vilcassim S, Low M, Fedele P, Motorna O, Roberts L, Gingold M, Gregory G. Ong J, et al. Among authors: low m. Ann Hematol. 2022 Jul;101(7):1593-1594. doi: 10.1007/s00277-022-04787-x. Epub 2022 Feb 13. Ann Hematol. 2022. PMID: 35152313 No abstract available.

6

Indolent T Cell Lymphoproliferation of the Gastrointestinal Tract: An Evolving Disease Entity.

Wang L, Koh E, Kumar B, Low MSY. Wang L, et al. Hematol Rep. 2024 Mar 22;16(2):179-184. doi: 10.3390/hematolrep16020018. Hematol Rep. 2024. PMID: 38525693 Free PMC article.

7

Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells.

Teh CE, Gong JN, Segal D, Tan T, Vandenberg CJ, Fedele PL, Low MSY, Grigoriadis G, Harrison SJ, Strasser A, Roberts AW, Huang DCS, Nolan GP, Gray DHD, Ko ME. Teh CE, et al. Cell Death Differ. 2020 Jul;27(7):2217-2233. doi: 10.1038/s41418-020-0498-z. Epub 2020 Jan 27. Cell Death Differ. 2020. PMID: 31988495 Free PMC article.

8

Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?

Low M, Infantino S, Grigoriadis G, Tarlinton D. Low M, et al. Immunol Rev. 2016 Mar;270(1):78-94. doi: 10.1111/imr.12388. Immunol Rev. 2016. PMID: 26864106 Review.

9

Neurology of Fabry disease.

Low M, Nicholls K, Tubridy N, Hand P, Velakoulis D, Kiers L, Mitchell P, Becker G. Low M, et al. Intern Med J. 2007 Jul;37(7):436-47. doi: 10.1111/j.1445-5994.2007.01366.x. Intern Med J. 2007. PMID: 17547722 Clinical Trial.

10

Anabolic androgenic steroids, an easily forgotten cause of polycythaemia and cerebral infarction.

Low MS, Vilcassim S, Fedele P, Grigoriadis G. Low MS, et al. Intern Med J. 2016 Apr;46(4):497-9. doi: 10.1111/imj.13029. Intern Med J. 2016. PMID: 27062206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

884 results

Search Page

Filters